Breaking News

ICON Launches Early Phase Imaging Solution

By Gil Roth | October 17, 2012

Streamlined offering designed to support faster early phase decision making

ICON has launched a new medical imaging solution tailored to the unique requirements of early phase trials. This new solution incorporates streamlined processes and procedures to maximize the information collected from image data and to ensure that this information is processed rapidly in line with the shorter timelines and requirements of early-phase research, according to the company. Enhanced decision making is then enabled by MIRA, ICON’s image management system, which standardizes data from all imaging formats and allows for centralized analysis and interpretation of data.

ICON Medical Imaging’s early phase group will be led by Dr. James Conklin, senior vice president, Medical and Scientific Affairs, and Dr. Valerie Treyer, director, Medical and Scientific Affairs, who together have more than 45 years of experience in the management of medical image data used in clinical trials. The group will work closely with ICON Development Solutions.

“PET, volumetrics, advanced CT and MRI are increasingly being used in early phase research which has created a demand for more tailored imaging solutions for early phase trials,” said Ted Gastineau, president, ICON Medical Imaging. “We have developed a unique and cost-effective solution that provides true insight to the data generated from imaging technologies and helps clients decide earlier about the future success of a drug.”

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016